A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors
Abstract Introduction Disulfiram (DSF) is an inhibitor of acetaldehyde dehydrogenase and is currently used for the treatment of alcoholism. Preclinical studies have shown that the DSF metabolite dithiocarbamate, can bind to copper (Cu) and form bis-(diethyldithiocarbamate)-copper (CuET) that has ant...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2026-02-01
|
| coleção: | BMC Cancer |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12885-026-15743-7 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
